US Medical Radiopharmaceuticals Market
US Medical Radiopharmaceuticals Market
New Growth Opportunities Emerge in a Strenuous Market
RELEASE DATE
26-Sep-2013
26-Sep-2013
REGION
North America
North America
Research Code: NC7B-01-00-00-00
SKU: MX00050-NA-MR_17562
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
MX00050-NA-MR_17562
Description
This research service pertains to the US market for medical radiopharmaceuticals. A thorough market sizing and forecasting model of market revenue, procedure volumes, and average pricing is included, along with analyses of market trends, drivers and restraints, and the reimbursement and the competitive environments at the total level as well as within each segment. The three market segments considered are diagnostic SPECT radiopharmaceuticals, diagnostic PET radiopharmaceuticals and therapeutic radiopharmaceuticals. The base year of the study is 2012 and the forecast period extends seven years through 2019.
Table of Contents
Executive Summary
Executive Summary (continued)
Executive Summary—Market Engineering Measurements
Executive Summary—Market Engineering Measurements (continued)
Executive Summary—CEO’s Perspective
Market Overview—Definitions
Market Overview—Definitions (continued)
Market Overview—Introduction
Market Overview—Distribution Structure and Clinical Applications
Distribution Structure and Clinical Applications Discussion
Market Overview—Scope of Study
Market Overview—Key Questions This Study Will Answer
Market Overview—Segmentation
Market Overview—Segmentation (continued)
Drivers and Restraints
Drivers—Impact and Duration
Drivers Explained
Drivers Explained (continued)
Drivers Explained (continued)
Drivers Explained (continued)
Drivers Explained (continued)
Restraints—Impact and Duration
Restraints Explained
Restraints Explained (continued)
Restraints Explained (continued)
Restraints Explained (continued)
Restraints Explained (continued)
Restraints Explained (continued)
Total Medical Radiopharmaceuticals Market— Introduction
Total Medical Radiopharmaceuticals Market— Introduction (continued)
Market Engineering Measurements
Market Engineering Measurements (continued)
Forecast Assumptions
Total Medical Radiopharmaceuticals Market—Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Total Medical Radiopharmaceuticals Market—Revenue Forecast by Segment
Revenue Forecast by Segment Discussion
Radiopharmaceutical Reimbursement—Introduction
Reimbursement of Procedures Involving Use of Radiopharmaceuticals
Reimbursement of Procedures Involving Use of Radiopharmaceuticals (continued)
Reimbursement of Procedures Involving Use of Radiopharmaceuticals (continued)
Reimbursed Radiopharmaceuticals Billing Codes
Reimbursed Radiopharmaceuticals Billing Codes (continued)
Reimbursed Radiopharmaceuticals Billing Codes (continued)
Reimbursed Radiopharmaceuticals Billing Codes (continued)
Key Industry Participants and Main Product Lines
Competitive Analysis—Market Share
Market Share Analysis
Radiopharmacy Facility Landscape
Competitive Environment
Competitive Factors and Assessment
Diagnostic SPECT Radiopharmaceuticals Segment Breakdown
Diagnostic SPECT Radiopharmaceuticals Segment—Market Engineering Measurements
Diagnostic SPECT Radiopharmaceuticals Segment—Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Diagnostic SPECT Radiopharmaceuticals Segment—Procedure Volume Forecast
Procedure Volume Forecast Discussion
Diagnostic SPECT Radiopharmaceuticals Segment—Pricing Trends and Forecast
Pricing Trends and Forecast Discussion
Competitive Analysis—Market Share
Market Share Analysis
Diagnostic PET Radiopharmaceuticals Segment Breakdown
Diagnostic PET Radiopharmaceuticals Segment—Market Engineering Measurements
Diagnostic PET Radiopharmaceuticals Segment—Revenue Forecast
Revenue Forecast Discussion
Diagnostic PET Radiopharmaceuticals Segment—Procedure Volume Forecast
Procedure Volume Forecast Discussion
Procedure Volume Forecast Discussion (continued)
Diagnostic PET Radiopharmaceuticals Segment—Pricing Trends and Forecast
Pricing Trends and Forecast Discussion
Competitive Analysis—Market Share
Market Share Analysis
Radioimmunotherapy Agents Segment—Background
Radioimmunotherapy Agents Segment—Introduction
Radioimmunotherapy Agents Segment Breakdown
Radioimmunotherapy Agents Segment—Market Engineering Measurements
Radioimmunotherapy Agents Segment—Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Revenue Forecast Discussion (continued)
Revenue Forecast Discussion (continued)
Revenue Forecast Discussion (continued)
The Last Word—Three Big Predictions
Legal Disclaimer
Market Engineering Methodology
Learn More—Next Steps
This research service pertains to the US market for medical radiopharmaceuticals. A thorough market sizing and forecasting model of market revenue, procedure volumes, and average pricing is included, along with analyses of market trends, drivers and restraints, and the reimbursement and the competitive environments at the total level as well as within each segment. The three market segments considered are diagnostic SPECT radiopharmaceuticals, diagnostic PET radiopharmaceuticals and therapeutic radiopharmaceuticals. The base year of the study is 2012 and the forecast period extends seven years through 2019.
No Index | No |
---|---|
Podcast | No |
Author | Nadim Daher |
Industries | Healthcare |
WIP Number | NC7B-01-00-00-00 |
Is Prebook | No |